Preoperative immunonutrition decreases postoperative complications by modulating prostaglandin E2 production and T-cell differentiation in patients undergoing pancreatoduodenectomy

Surgery (United States)

Volumn 155, Issue 1, 2014, Pages 124-133

  Aida, Toshiaki ^a   Furukawa, Katsunori ^a   Suzuki, Daisuke ^a   Shimizu, Hiroaki ^a   Yoshidome, Hiroyuki ^a   Ohtsuka, Masayuki ^a   Kato, Atsushi ^a   Yoshitomi, Hideyuki ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ARGININE; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; RNA; FATTY ACID;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; FOOD INTAKE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNONUTRITION; INFECTIOUS COMPLICATION; MALE; NUTRITIONAL SUPPORT; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; BLOOD; CELLULAR IMMUNITY; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; PREOPERATIVE CARE; TH1 TH2 BALANCE;

AGED; ARGININE; CELL DIFFERENTIATION; DIETARY SUPPLEMENTS; DINOPROSTONE; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RNA; TH1-TH2 BALANCE;

EID: 84899475301     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.05.040     Document Type: Article

References (42)

1. DeOliveira ML, Winter JM, Schafer M, et al. Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 2006; 244: 931-7.
2. Braga M, Capretti G, Pecorelli N, et al. A prognostic score to predict major complications after pancreaticoduodenectomy. Ann Surg 2011; 254: 702-7.
3. Meakins JL. Host defense mechanisms in surgical patients: effect of surgery and trauma. Acta Chir Scand Suppl 1989; 550: 43-51.
4. Suzuki D, Furukawa K, Kimura F, et al. Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery 2010; 148: 573-81.
5. Giger U, Büchler M, Farhadi J, et al. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncl 2007; 14: 2798-806.
6. Braga M, Gianotti L, Vignali A, et al. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002; 132: 805-14.
7. Furukawa K, Tashiro T, Yamamori H, et al. Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. Ann Surg 1999; 229: 255-61.
8. Hayashi N, Tashiro T, Yamamori H, et al. Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition 1999; 15: 135-9.
9. Palombo JD, DeMichele SJ, Boyce PJ, et al. Effect of shortterm enteral feeding with eicosapentaenoic and gammalinolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med 1999; 27: 1908-15.
10. Mancuso P, Whelan J, DeMichele SJ, et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 1997; 25: 523-32.
11. Fischer A, Durandy A, Griscelli C. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity. J Immunol 1981; 126: 1452-5.
12. Walker C, Kristensen F, Bettens F, et al. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2- induced inhibition of interleukin 2 production. J Immunol 1983; 130: 1770-3.
13. Smyth EM, Grosser T, Wang M, et al. Prostanoids in health and disease. J Lipid Res 2009;50(Suppl):S423-8.
14. Furukawa K, KobayashiM, Herndon DN, et al. Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: role in the subsequent development of burnassociated type 2 T-cell responses. Ann Surg 2002; 236: 112-9.
15. Furukawa K, Kobayashi M, Sasaki H, et al. Cryptococcal encephalitis in thermally injured mice is accelerated by type 2 T-cell responses. Crit Care Med 2002; 30: 1419-24.
16. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146: 108-13.
17. Gianotti L, Braga M, Gentilini O, Balzano G, Zerbi A, Di Carlo V. Artificial nutrition after pancreaticoduodenectomy. Pancreas 2000; 21: 344-51.
18. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, IzbickiJ, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138: 8-13.
19. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007; 142: 761-8.
20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.
21. Clavien PA, Barkun J, de Oliveira ML. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96.
22. Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
23. Senkal M, Zumtobel V, Bauer KH, et al. Outcome and costeffectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999; 134: 1309-16.
24. Gianotti L, Braga M, Fortis C, et al. A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status. JPEN J Parenter Enteral Nutr 1999; 23: 314-20.
25. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992; 112: 56-67.
26. Weimann A, Braga M, Harsanyi L, et al. ESPEN Guidelines on Enteral Nutrition: surgery including organ transplantation. Clin Nutr 2006; 25: 224-44.
27. Barbas AS, Turley RS, Ceppa EP, et al. Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. J Am Geriatr Soc 2012; 60: 344-50.
28. Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative biliary decompression on pancreaticoduodenectomyassociated morbidity in 300 consecutive patients. Ann Surg 2001; 234: 47-55.
29. Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg 2011; 253: 879-85.
30. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227-57.
31. Decker D, Schondorf M, Bidlingmaier F, et al. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and upregulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996; 119: 316-25.
32. Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100: 655-69.
33. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89: 587-96.
34. Palombo JD, DeMichele SJ, Lydon EE, et al. Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acids. Am J Clin Nutr 1996; 63: 208-19.
35. Brash AR. Arachidonic acid as a bioactive molecule. J Clin Invest 2001; 107: 1339-45.
36. Hilkens CM, Vermeulen H, van Neerven RJ, et al. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 1995; 25: 59-63.
37. Trebble TM, Wootton SA, Miles EA, et al. Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr 2003; 78: 376-82.
38. Caristi S, Piraino G, Cucinotta M, et al. Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes. J Biol Chem 2005; 280: 14433-42.
39. Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 2009; 15: 633-40.
40. Sreeramkumar V, Fresno M, Cuesta N. Prostaglandin E2 and T cells: friends or foes? Immunol Cell Biol 2012; 90: 579-86.
41. Bansal V, Syres KM, Makarenkova V, et al. Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets. JPEN J Parenter Enteral Nutr 2005;29(1 Suppl):S75-80.
42. Marik PE, Zaloga GP. Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr 2010; 34: 378-86.